GlassScriptPhysician profile
Alexis Lorente
NPI 1386268902
$1,939.88
in general payments reported to CMS, 2019-2025
19 companies · $222 in 2025
The $222 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $657 · 2022: $360 · 2023: $544 · 2024: $156 · 2025: $222.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $922.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $922.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $350.25 | 2021-2023 | |
| Myovant Sciences INC. | $344.45 | 2021-2022 | |
| Hologic Sales and Service, LLC | $191.57 | 2022-2025 | Thinprep 2000 Processor, Aptima |
| Procept Biorobotics Corporation | $166.87 | 2025 | |
| Daiichi Sankyo INC. | $143.19 | 2021-2022 | |
| Exeltis, USA INC. | $128.24 | 2022-2024 | Slynd, Tyblume |
| Astellas Pharma US INC | $124.81 | 2023 | Veozah |
| Axonics, INC. | $113.07 | 2021-2023 | Axonics |
| Therapeuticsmd, INC. | $69.51 | 2021 | |
| Mayne Pharma Commercial LLC | $64.06 | 2023 | |
| Organon LLC | $44.16 | 2022-2023 | Nexplanon |
| Evofem Biosciences, INC. | $40.00 | 2024-2025 | Phexxi, Solosec, Phexx |
| Mycovia Pharmaceuticals, INC. | $28.30 | 2023 | Vivjoa |
| Mission Pharmacal Company | $28.07 | 2021 | |
| Becton, Dickinson and Company | $27.56 | 2023 | Bd Onclarity |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ascend Therapeutics US, LLC | $23.26 | 2023 | |
| Millicent US INC | $18.76 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.97 | 2021 | |
| Exact Sciences Corporation | $15.78 | 2023 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexis Lorente listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.